Lv1
42 积分 2022-11-01 加入
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)
1个月前
已完结
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
1个月前
已完结
Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study
1个月前
已完结
Gene expression profiling reveals 2 overarching types of ALCL with distinct targetable biology: an LLMPP study
2个月前
已关闭
Mediastinal Germ Cell Tumor and Acute Megakaryoblastic Leukemia With Co-occurring KRAS Mutation and Complex Cytogenetics
3个月前
已完结
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B-cell lymphoma
5个月前
已完结
Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy
5个月前
已完结
Regulatory T cells in cancer immunotherapy
5个月前
已完结
Microenvironmental regulation of solid tumour resistance to CAR T cell therapy
5个月前
已完结
Differentiation of transplanted haematopoietic stem cells tracked by single-cell transcriptomic analysis
5个月前
已完结
皖公网安备34019202002308
